Flexible nano-liposomes-based transdermal hydrogel for targeted delivery of dexamethasone for rheumatoid arthritis therapy
Rheumatoid arthritis (RA) is an inflammatory immune-mediated disease that can lead to synovitis, cartilage destruction, and even joint damage. Dexamethasone (DEX) is a commonly used agent for RA therapy on inflammation manage. However, the traditional administering DEX is hampered by low efficiency...
Saved in:
Main Authors: | Yi-Pu Zhao (Author), Jiang-Fan Han (Author), Fei-Yue Zhang (Author), Tian-Tian Liao (Author), Ren Na (Author), Xiao-Feng Yuan (Author), Guang-bin He (Author), Weiliang Ye (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melittin promotes dexamethasone in the treatment of adjuvant rheumatoid arthritis in rats
by: Linfu Yang, et al.
Published: (2024) -
Palmitoylethanolamide-Incorporated Elastic Nano-Liposomes for Enhanced Transdermal Delivery and Anti-Inflammation
by: Chuanpeng Ren, et al.
Published: (2024) -
Comparative study of liposomes and liposomes-in-polymer hydrogel as transdermal carriers for improving the topical delivery of imperatorin
by: Junfeng BAN, et al.
Published: (2021) -
Liposomal Nanosystems in Rheumatoid Arthritis
by: Margarida Ferreira-Silva, et al.
Published: (2021) -
Transdermal delivery of triptolide-phospholipid complex to treat rheumatoid arthritis
by: Xin-Yi Liu, et al.
Published: (2021)